| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2011 | WO2011025086A1 Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide |
| 03/03/2011 | WO2011025036A1 Particle composition and medicinal composition comprising same |
| 03/03/2011 | WO2011025006A1 Gpr119 agonist |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
| 03/03/2011 | WO2011024942A1 Matrix metalloprotease-2 (mmp-2) inhibitor |
| 03/03/2011 | WO2011024933A1 3-(biaryloxy) propionic acid derivative |
| 03/03/2011 | WO2011024932A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024873A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024872A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024871A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024869A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024850A1 The use of lpa for encouraging pregnancy, and fertility agent |
| 03/03/2011 | WO2011024711A1 Novel compound amycolose derivative, and production process and use of same |
| 03/03/2011 | WO2011024620A1 Antimycotic pharmaceutical composition |
| 03/03/2011 | WO2011024480A1 Drug composition for angiogenesis therapy |
| 03/03/2011 | WO2011024468A1 Novel sulfonamide derivative and pharmaceutical product containing same |
| 03/03/2011 | WO2011024467A1 Orally administrable tablet for intestinal lavage |
| 03/03/2011 | WO2011024428A1 Breast cancer related gene c12orf32 |
| 03/03/2011 | WO2011024354A1 Transdermal composition of phosphatidylcholine and method for producing same |
| 03/03/2011 | WO2011024208A1 Combination dosage form with acetylsalicylic acid, calcitriol and calcium |
| 03/03/2011 | WO2011024168A2 Sustained release delivery systems for the prevention and treatment of head and neck cancers |
| 03/03/2011 | WO2011024157A1 Nucleic acid sequences related to cancer |
| 03/03/2011 | WO2011024156A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders |
| 03/03/2011 | WO2011024154A1 Use of irbesartan for the preparation of a medicament for the prevention of hospitalization for heart failure. |
| 03/03/2011 | WO2011024122A1 Pharmaceutical compositions for treating ibd |
| 03/03/2011 | WO2011024115A1 Composition and method for treating cognitive impairments in down syndrom subjects |
| 03/03/2011 | WO2011024078A1 3 -oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments |
| 03/03/2011 | WO2011024056A2 An improved process for the preparation of bosentan |
| 03/03/2011 | WO2011024029A1 Fast disintegrating dosage forms of cinnarizine and dimenhydrinate combination |
| 03/03/2011 | WO2011024028A1 Direct compression tablets of otilonium |
| 03/03/2011 | WO2011024027A1 Pharmaceutical combinations of diflucortolone and terbinafine |
| 03/03/2011 | WO2011024004A1 Heterocyclic urea derivatives useful for treatment of bacterial infection |
| 03/03/2011 | WO2011024001A1 Np-1 antagonists and their therapeutic use |
| 03/03/2011 | WO2011023989A1 Aromatase inhibitor |
| 03/03/2011 | WO2011023986A1 Kinase inhibitors |
| 03/03/2011 | WO2011023970A1 Fulvic acid compositions and their use |
| 03/03/2011 | WO2011023883A1 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents |
| 03/03/2011 | WO2011023864A1 Pseudodipeptides as mmp inhibitors |
| 03/03/2011 | WO2011023824A2 Estrogen receptor modulators for the treatment of diseases involving plasmacytoid dendritic cells |
| 03/03/2011 | WO2011023812A1 Microsomal prostaglandin e synthase-1 (mpges1) inhibitors |
| 03/03/2011 | WO2011023796A1 Bifeprunox for treating addiction |
| 03/03/2011 | WO2011023795A1 (thio)morpholine derivatives as s1p modulators |
| 03/03/2011 | WO2011023773A1 Compounds and compositions as protein kinase inhibitors |
| 03/03/2011 | WO2011023753A1 Benzoxazine derivatives as glycine transport inhibitors |
| 03/03/2011 | WO2011023734A1 Process for the precipitation of inhalable pharmaceutical agents in the propellant |
| 03/03/2011 | WO2011023733A1 Anhydrate forms of a pyridine derivative |
| 03/03/2011 | WO2011023722A1 Novel quinoxalinone hepcidin antagonists |
| 03/03/2011 | WO2011023703A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/03/2011 | WO2011023696A1 Methylpyrrolopyridinecarboxamides |
| 03/03/2011 | WO2011023693A1 Methylpyrrolopyrimidinecarboxamides |
| 03/03/2011 | WO2011023677A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators |
| 03/03/2011 | WO2011023667A1 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | WO2011023626A1 Pyrrolidine derivatives as nk3 receptor antagonists |
| 03/03/2011 | WO2011023624A1 Bisphosphonates as inhibitors of acid sphingomyelinase |
| 03/03/2011 | WO2011023585A1 Piperidine derivatives used as orexin antagonists |
| 03/03/2011 | WO2011023578A1 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder |
| 03/03/2011 | WO2011023573A1 Antimicrobial amino-salicylic acid derivatives |
| 03/03/2011 | WO2011023392A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an antiepileptic |
| 03/03/2011 | WO2011023304A2 Novel antiparasitic combination of active substances |
| 03/03/2011 | WO2011023287A1 Use of faa and its derivatives in cosmetics and dermatology |
| 03/03/2011 | WO2011023146A1 Imatinib mesylate polymorphs generated by crystallization in aqueous inorganic salt solutions |
| 03/03/2011 | WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | WO2011023013A1 Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses |
| 03/03/2011 | WO2011022944A1 Use of lanostanes and extracts from poria cocos for treating diabetes |
| 03/03/2011 | WO2011022928A1 Quinolines compounds, their preparation methods, pharmaceutical compositions containing the same and use thereof |
| 03/03/2011 | WO2011022861A1 Fulvestrant nanosphere/microsphere and preparative method and use thereof |
| 03/03/2011 | WO2011022838A1 Polyhydroxylated bile acids for treatment of biliary disorders |
| 03/03/2011 | WO2011022805A1 Novel colchicine derivatives, methods and uses thereof |
| 03/03/2011 | WO2011022798A1 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same |
| 03/03/2011 | WO2011022786A1 Methods for diagnosis and treatment of chronic fatigue syndrome |
| 03/03/2011 | WO2011022782A1 Combinations comprising imatinib mesylate and diclofenac |
| 03/03/2011 | WO2011022781A1 Treatment of macular degeneration |
| 03/03/2011 | WO2011022772A1 Combination therapy for treating proliferative diseases |
| 03/03/2011 | WO2011022757A1 Purine-targeted diagnosis and therapy of wounds |
| 03/03/2011 | WO2011006908A3 Metal complexes having dual histone deacetylase inhibitory and dna-binding activity |
| 03/03/2011 | WO2011006794A8 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
| 03/03/2011 | WO2011005354A9 Gallium formulation for the treatment and prevention of infectious diseases |
| 03/03/2011 | WO2011004393A3 Para amino benzoic acid based nanotubes |
| 03/03/2011 | WO2011004162A3 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer |
| 03/03/2011 | WO2011003858A3 Pharmaceutical compositions and solid forms |
| 03/03/2011 | WO2011002425A3 Pharmaceutical composition increasing solubility and stability |
| 03/03/2011 | WO2011002423A3 Solubility enhancing pharmaceutical composition |
| 03/03/2011 | WO2011000563A4 Eltoprazine for the treatment of weight disorders |
| 03/03/2011 | WO2010147957A3 Dithiol compounds, derivatives, and uses therefor |
| 03/03/2011 | WO2010147947A3 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
| 03/03/2011 | WO2010146348A3 Crystalline form of pemirolast |
| 03/03/2011 | WO2010146341A3 Crystalline form of pemirolast |
| 03/03/2011 | WO2010145644A3 Composition for transporting orotic acid across the blood-brain barrier |
| 03/03/2011 | WO2010145197A8 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors |
| 03/03/2011 | WO2010142805A4 New potent anti apob antisense compounds |
| 03/03/2011 | WO2010131962A3 Lysine compounds and their use in site- and chemoselective modification of peptides and proteins |
| 03/03/2011 | WO2010129337A3 New oral formulations for tetrapyrrole derivatives |
| 03/03/2011 | WO2010129273A3 Butaclamol for the treatment of amyotrophic lateral sclerosis |
| 03/03/2011 | WO2010128788A3 Anti-obesity external dermal agent compositions containing capsaicin or capsaicin-like compounds as active ingredients |
| 03/03/2011 | WO2010128528A9 Piperidine derivatives useful for treatment of diebetes |
| 03/03/2011 | WO2010128525A4 A formulation of ivabradine for treating the cardiovascular disease |
| 03/03/2011 | WO2010126168A3 Solid preparation |